August 10, 2013 A Brief Look At Shorts Short Interest Analysis of the MTSL With the vast majority of public companies still in the development stage and therefore rely on a single lead compound for success or failure, short selling is common in biotech stocks. Short selling is the selling of a security that the[…]
To access this post, you must have an active subscription to the Medical Technology Stock Letter. Please login if you are a current subscriber. Thank you.